Suppr超能文献

身份识别的未来能否摆脱其过去的惯性教条?“越短越好”以及“口服是新的静脉注射”的范例。

Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV.

作者信息

Davar Kusha, Clark Devin, Centor Robert M, Dominguez Fernando, Ghanem Bassam, Lee Rachael, Lee Todd C, McDonald Emily G, Phillips Matthew C, Sendi Parham, Spellberg Brad

机构信息

Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, California, USA.

Department of Medicine, Birmingham Veterans Affairs (VA) Medical Center, Birmingham, Alabama, Birmingham, Alabama, USA.

出版信息

Open Forum Infect Dis. 2022 Dec 29;10(1):ofac706. doi: 10.1093/ofid/ofac706. eCollection 2023 Jan.

Abstract

Like all fields of medicine, Infectious Diseases is rife with dogma that underpins much clinical practice. In this study, we discuss 2 specific examples of historical practice that have been overturned recently by numerous prospective studies: traditional durations of antimicrobial therapy and the necessity of intravenous (IV)-only therapy for specific infectious syndromes. These dogmas are based on uncontrolled case series from >50 years ago, amplified by the opinions of eminent experts. In contrast, more than 120 modern, randomized controlled trials have established that shorter durations of therapy are equally effective for many infections. Furthermore, 21 concordant randomized controlled trials have demonstrated that oral antibiotic therapy is at least as effective as IV-only therapy for osteomyelitis, bacteremia, and endocarditis. Nevertheless, practitioners in many clinical settings remain refractory to adopting these changes. It is time for Infectious Diseases to move beyond its history of eminent opinion-based medicine and truly into the era of evidenced-based medicine.

摘要

与所有医学领域一样,传染病学充斥着支撑诸多临床实践的教条。在本研究中,我们讨论了两个历史实践的具体例子,它们最近已被众多前瞻性研究所推翻:抗菌治疗的传统疗程以及特定感染综合征仅采用静脉注射(IV)治疗的必要性。这些教条基于50多年前的非对照病例系列,并因知名专家的观点而被放大。相比之下,120多项现代随机对照试验已证实,较短疗程的治疗对许多感染同样有效。此外,21项一致的随机对照试验表明,对于骨髓炎、菌血症和心内膜炎,口服抗生素治疗至少与仅采用静脉注射治疗一样有效。然而,许多临床环境中的从业者仍然难以接受这些变化。传染病学是时候超越其基于权威观点的医学历史,真正进入循证医学时代了。

相似文献

1
Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV.
Open Forum Infect Dis. 2022 Dec 29;10(1):ofac706. doi: 10.1093/ofid/ofac706. eCollection 2023 Jan.
2
Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review.
Am J Med. 2022 Mar;135(3):369-379.e1. doi: 10.1016/j.amjmed.2021.10.007. Epub 2021 Oct 27.
5
Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
Health Technol Assess. 2019 Aug;23(38):1-92. doi: 10.3310/hta23380.
7
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
Antimicrobial use in critically ill horses.
J Vet Emerg Crit Care (San Antonio). 2015 Jan-Feb;25(1):89-100. doi: 10.1111/vec.12275. Epub 2015 Jan 13.
10
Antibiotic treatment of common infections: more evidence to support shorter durations.
Curr Opin Infect Dis. 2020 Dec;33(6):433-440. doi: 10.1097/QCO.0000000000000680.

引用本文的文献

1
Antibiotic therapy for severe bacterial infections.
Intensive Care Med. 2025 Sep 1. doi: 10.1007/s00134-025-08063-0.
3
Health Economic Analysis of an All-Virtual, At-Home Acute Care Model.
JAMA Netw Open. 2025 Jun 2;8(6):e2517114. doi: 10.1001/jamanetworkopen.2025.17114.
4
Evaluation of shorter versus longer antifungal treatment durations for . urinary tract infections among hospitalized adults.
Antimicrob Agents Chemother. 2025 Jun 4;69(6):e0192024. doi: 10.1128/aac.01920-24. Epub 2025 Apr 22.
6
Managing Bacteremia: Insights Into Pathogen-Specific Treatment.
Cureus. 2025 Feb 7;17(2):e78674. doi: 10.7759/cureus.78674. eCollection 2025 Feb.
7
Short versus long treatment duration for streptococcal bloodstream infection.
Antimicrob Steward Healthc Epidemiol. 2025 Feb 17;5(1):e47. doi: 10.1017/ash.2025.29. eCollection 2025.
9
Sustainable solutions to the continuous threat of antimicrobial resistance.
Health Aff Sch. 2025 Jan 24;3(2):qxaf012. doi: 10.1093/haschl/qxaf012. eCollection 2025 Feb.
10
Outpatient Oral Doxycycline Therapy for Ocular Syphilis.
JAMA Netw Open. 2024 Dec 2;7(12):e2449364. doi: 10.1001/jamanetworkopen.2024.49364.

本文引用的文献

2
Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial.
Lancet Infect Dis. 2023 Mar;23(3):371-379. doi: 10.1016/S1473-3099(22)00528-X. Epub 2022 Oct 6.
4
Short-course antibiotics for common infections: what do we know and where do we go from here?
Clin Microbiol Infect. 2023 Feb;29(2):150-159. doi: 10.1016/j.cmi.2022.08.024. Epub 2022 Sep 6.
5
How to change the course: practical aspects of implementing shorter is better.
Clin Microbiol Infect. 2023 Nov;29(11):1402-1406. doi: 10.1016/j.cmi.2022.07.025. Epub 2022 Aug 19.
6
Shorter antibiotic courses in the immunocompromised: the impossible dream?
Clin Microbiol Infect. 2023 Feb;29(2):143-149. doi: 10.1016/j.cmi.2022.08.007. Epub 2022 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验